Received Sep 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (UNKNOWN)) | UNKNOWN MANUFACTURER | UNK | 5683MF008 | OT / LA |
Minimal side effects no nearly as intense as with mRNA; Very mild body aches; Tested positive once for Covid 19, on 10Feb2024, after having the Novavax vaccine in 2023; This non serious initial spontaneous report was reported by a Nurse via Contact Center (MI No. NOV25-00655) and concerns a 64-year-old Female who experienced "VERY MILD BODY ACHES", "MINIMAL SIDE EFFECTS NO NEARLY AS INTENSE AS WITH MRNA" on unknown dates and "TESTED POSITIVE ONCE FOR COVID 19, ON 10FEB2024, AFTER HAVING THE NOVAVAX VACCINE IN 2023" on 10-Feb-2024 after receiving COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) on 30-Oct-2023. At the time of the report, the outcome of the Pain, Adverse event, Breakthrough COVID-19 was Unknown.; Sender's Comments: This 64-year-old Female experienced Pain, Adverse event and Breakthrough COVID-19 after vaccination with COVID-19 Vaccine, Adjuvanted (2023-2024 Formula). The event Pain, Adverse event, and Breakthrough COVID-19 were reported as non-serious. Based on the spontaneous nature of the report, the causal relationship between COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) and Breakthrough COVID-19, Pain and Adverse event is considered Possible.
Bone marrow disorder NOS
Medical History/Concurrent Conditions: Osteoporosis; Smoldering myeloma
ELETRIPTAN; AZELASTINE; CALCIUM CITRATE; VIT D3; MAGNESIUM GLYCINATE; VITAMIN B 12 COMPLEX
Test Date: 20240210; Test Name: SARS-COV-2 RAPID DIAGNOSTIC TEST; Result Unstructured Data: Positive